This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: COF QCOM DECK HOT ESRX

Stocks in this article: COF QCOM DECK SPLS HOT ESRX SEE VVUS FSLR

Analog Devices target raised at Jefferies to $51, Jefferies said. Improving order rates. Hold rating.

BJ's Restaurants (BJRI) numbers lowered at Oppenheimer. Shares of BJRI now seen reaching $38, Oppenheimer said. Estimates also lowered as model remains challenged. Outperform rating.

Bruker (BRKR) numbers raised at UBS. Shares of BRKR now seen reaching $21, UBS said. Estimates also increased on double digit organic growth and EPS beat in 4Q. Buy rating.

Conagra (CAG) estimates, target raised at Credit Suisse. Shares of CAG now seen reaching $36, according to Credit Suisse. Estimates also increased, as the company is carrying a lot of momentum into 2013. Neutral rating.

Chemed Corporation (CHE) target raised at Oppenheimer to $91, Oppenheimer said. Fourth quarter beat. Outperform rating.

Express Scripts (ESRX) numbers boosted at Lazard. Shares of ESRX now seen reaching $65, according to Lazard Capital Markets. Estimates also upped, given better operating trends. Buy rating.

Express estimates, target boosted at Wedbush. Shares of EXPR now seen reaching $22, according to Wedbush. Estimates also upped, given positive early checks on the Spring season. Outperform rating.

First Solar (FSLR) numbers raised at UBS. Shares of FSLR now seen reaching $36, UBS said. Estimates also increased on expected guide up for 2013 on higher margins. Neutral rating.

Medtronic (MDT) estimates, target increased at BMO. MDT estimates were raised through 2015, BMO Capital said. Company continues to grow across the board. Outperform rating and new $52 price target.

Omnicare (OCR) estimates, target upped at JP Morgan. OCR estimates were boosted through 2014, JP Morgan said. Company raised its guidance. Overweight rating and new $45 price target.

Qualcomm (QCOM) added to Conviction Buy List at Nomura. QCOM was placed on the US Conviction Buy list, according to Nomura. Company is a market leader and should see improving traction in China. $75 price target.

Realogy (RLGY) estimates, target raised at JP Morgan. Shares of RLGY now seen reaching $51, according to JP Morgan. Estimates also increased, given better business trends. Overweight rating.

Sealed Air (SEE) numbers raised at Jefferies. Shares of SEE now seen reaching $25, Jefferies said. Estimates also raised on hard stance on pricing and restructuring underway. Buy rating.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs